Case Study: Leading Biotech Company accelerates facility launch with Körber AG

How Körber’s pharma consultants enable a successful facility launch

Körber AG supported a leading biotech company specializing in mRNA medicines and vaccines as it launched new facilities in Australia and Canada. The customer needed to qualify a Körber Switch 350 inspection machine under a tight funding-driven timeline, while also dealing with newly established processes, limited in-house machine qualification experience, and coordination across multiple time zones and stakeholders.

Körber AG provided agile machine qualification support, extending its consulting scope to help with specifications, test strategies, protocols, SOPs, and risk-based single-test execution focused only on functions affected by relocation. This approach accelerated qualification, improved team readiness, and enabled faster commissioning of the Switch 350, helping the customer shorten time to production and go into operation more efficiently.